The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion

Cardiovascular Research

Volumn 32, Issue 4, 1996, Pages 743-751

  Lefer, Allan M ^a   Lefer, David J ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell adhesion molecules; Endothelium; Microcirculation; Neutrophils; Nitric oxide; Reperfusion; Selectins

Indexed keywords

ARGININE; CELL ADHESION MOLECULE; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PADGEM PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CAT; CONTROLLED STUDY; DOG; ISCHEMIA; MICROCIRCULATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION; NEUTROPHIL ACTIVATION; NITRIC OXIDE; REPERFUSION INJURY;

EID: 0030271193     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00073-9     Document Type: Review

References (70)

1. [1] Braunwald E, Kloner RA. Myocardial reperfusion: a double edged sword. J Clin Invest 1985;76:1713-1719.
2. [2] Farb A, Kolodgie FD, Jenkins M, Virmani R. Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidence. J Am Coll Cardiol 1993;21:1245-1253.
3. [3] Engler RL, Dahlgren MD, Morris DD, Paterson MA, Schmid-Schonbein AW. Role of leukocytes in response to acute myocardial ischemia reflow in dogs. Am J Physiol 1986;251:H314-H323.
4. [4] Barroso-Aranda J. Schmid-Schonbein GW, Zweifach BW, Engler RL. Granulocytes and no-reflow phenomena in irreversible hemorrhagic shock. Circ Res 1988;63:437-447.
5. [5] Bulkley GB. Mediators of splanchnic organ injury: overview and perspective. In: Marston A. Bulkley GB, Fiddian-Green RG, Haglund UH, eds. Splanchnic Ischemia and Multiple Organ Failure. London: Edward Arnold, 1989:183-194.
6. [6] Mehta JL, Nichols WW, Donnelly WH, Lawson DL, Saldeen TGP. Acetylcholine and bradykinin after occlusion-reperfusion. Circ Res 1989;64:43-54.
7. [7] Tsao PS, Aoki N. Lefer DJ, Johnson G, Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 1990;82:1402-1412.
8. [8] Lefer AM, Ma X-L. Endothelial dysfunction in the splanchnic circulation following ischemia and reperfusion. J Cardiovasc Pharmacol 1991;17(Suppl. 3):S186-S190.
9. [9] Tsao PS, Lefer AM. Time course and mechanism of endothelial dysfunction in isolated ischemic and hypoxic perfused rat hearts. Am J Physiol 1990;259:H1660-H1666.
10. [10] Buerke M, Weyrich AS, Lefer AM. Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil released mediators. Am J Physiol 1994;266:H128-H136.
11. [11] Smith CW, Entman ML, Lane CL, Beaudet AL, Ty TI, Youker K, Hawkins HK, Anderson DC. Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule-1. J Clin Invest 1991;88:1216-1223.
12. [12] Lefer AM, Tsao PS, Lefer DJ, Ma X-L. Role of endothelial dysfunction in the pathogenesis of reperfusion injury following myocardial ischemia. FASEB J 1991;5:2029-2034.
13. [13] Engler RL, Schmid-Schonbein GW, Pavlec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983;111:98-111.
14. [14] Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Meth 1985;14:157-167.
15. [15] Bevilacqua M, Nelson RM. Selectins. J Clin Invest 1993;91:379-387.
16. [16] Lefer AM, Weyrich AS, Buerke M. Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc Res 1994;28:289-294.
17. [17] Ruoslahti E. Integrins. J Clin Invest 1991;87:1-5.
18. [18] Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-434.
19. [19] McEver RP. GMP-140: a receptor for neutrophils and monocytes on activated platelet and endothelium. J Cell Biochem 1991;45:156-161.
20. [20] Weyrich AS, Buerke M, Albertine KH, Lefer AM. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J Leukocyte Biol 1995;57:45-55.
21. [21] Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gibbrone MA. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987;84:9238-42.
22. x-containing carbohydrate reduces infarct size following myocardial ischemia and prolonged reperfusion. Circulation, 1995;92:1-712.
23. [23] Kukielka GL, Lanek CL, Manning AM, Michael LH, Entman ML, Smith CW, Anderson DC. Induction of myocardial ELAM-1 by ischemia and reperfusion. (Abstract) FASEB J 1993;7:A1060.
24. [24] Albelda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (endoCAM/CD31]: a novel vascular cell-cell adhesion molecule. J Cell Biol 1991;114:1059-1068.
25. [25] Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993;178:449-460.
26. [26] Vaporciyan AA, DeLisser HM, Yan HC, Mendiguren II, Thomas SR, Jones ML, Ward PA, Albelda SM. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science (Wash. DC) 1993;262:1580-15892.
27. [27] Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67:1033-1036.
28. [28] Ma X-L, Tsao PS, Lefer AM. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest 1991;88:1237-1243.
29. [29] Winquist R, Frei P, Harrison P, McFarland M, Letts G, Van G, Andrews L, Rothlein R, Hintze T. An anti-CD-18 Mab limits infarct size in primates following ischemia and reperfusion. Circulation 1990;82:III-701a (Abstract).
30. [30] Simpson PJ, Todd RF, Fantone JC, Mickelson JK, Griffin JD, Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mol, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 1988;81:624-629.
31. [31] Weyrich AS, Ma X-L, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993;91:2620-2629.
32. [32] Lefer DJ, Flynn DM, Buda AJ. Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion. Am J Physiol 1996; 270: H88-H98.
33. [33] Ma X-L, Weyrich AS, Lefer DJ, Buerke M, Albertine KH, Kishimoto TK, Lefer AM. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation 1993;88:649-658.
34. [34] Buerke M, Weyrich AS, Murohara T, Queen C, Klingbeil CK, Co MS, Lefer AM. Humanized monoclonal antibody DREG-200 directed against L-selectin protects in feline myocardial reperfusion injury. J Pharmacol Exp Ther 1994;271:134-142.
35. [35] Winquist RJ, Van LG, Andrews GY, Rothlein LK, Dreyer B, Smith WJ, Hintze CW. Monoclonal antibody to intercellular adhesion molecule-1, but not to endothelial-leukocyte adhesion molecule-1, protects against myocardial ischemia/reperfusion damage in anesthetized monkeys. Circulation 1992;86:I-79(abstract).
36. [36] Ma X-L, Lefer DJ, Lefer AM, Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992;86:937-946.
37. [37] Lefer DJ, Flynn DM, Jeffords PR, Buda AJ. Combined inhibition of P-selectin and ICAM-1 reduces neutrophil accumulation and preserves coronary blood flow in the postischemic myocardium. J Invest Med 1995;43:312A (abstract).
38. [38] Gumina RJ, Schultz J, Yao Z, Kenny D, Warltier DC, Gross G, Newman PJ. Antibody to PECAM-1 reduces myocardial infarct size. J Invest Med 1995;43(Suppl 2):312A.
39. [39] Murohara T, Delyani JA, Albelda SM, Lefer AM. Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J. Immunol 1996;156:3550-3557.
40. [40] Redl H, Dinges HP, Buurman WA, et al. Expression of endothelial leukocyte adhesion molecule-1 in septic but not traumatic/hypovolemic shock in the baboon. Am J Pathol 1991;139:461-466.
41. x oligosaccharide. J Cell Biol 1992;117:895-902.
42. x-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest 1994;93:1140-1148.
43. x analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. Circulation 1994;90:2390-2401.
44. x-oligosaccharide in myocardial ischaemia and reperfusion injury. Cardiovasc Res 1995;30:965-974.
45. x-containing oligosaccharide exerts beneficial effects in murine traumatic shock. Am J Physiol 1994;267:H2124-H2131.
46. [46] Granger DN. Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukocyte Biol 1994;55:662-675.
47. [47] Davenpeck KL, Gauthier TW, Albertine KH, Lefer AM. Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. Am J Physiol 1994;267:H622-H630.
48. [48] Ma X-L, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993;72:403-412.
49. [49] Johnson G III, Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 1991;19:244-252.
50. [50] Aoki N, Johnson G III, Lefer AM. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol 1990;258:G275-G281.
51. [51] Johnson G III, Tsao PS, Mulloy D, Lefer AM. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther 1990;252:35-41.
52. [52] Siegfried MR, Carey C, Ma X-L, Lefer AM. Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol 1992;263: H771-H777.
53. [53] Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 1993;88:2337-2350.
54. [54] Siegfried MR, Erhardt J, Rider T, Ma X-L, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharrnacol Exp Ther 1992;260:668-675.
55. [55] Pabla R, Buda AJ, Flynn DM. Salzberg DB, Lefer DJ. Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am J Physiol 269:H1113-H1121.
56. [56] Weyrich AS, Ma X-L, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992;86:279-288.
57. [57] Nakanishi K, Vinten-Johansen J, Lefer DJ, Zhao Z, Fowler WC III, McGee DS, Johnston WE. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 1992;263:H1650-H1658.
58. [58] Weyrich AS, Ma X-L, Buerke M, et al. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res 1994;75:692-700.
59. [59] Radomski MW, Palmer RMJ, Moncada S. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987;92:639-644.
60. [60] Kubes P, Suzuki M, Granger D. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-4655.
61. [61] Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 1994;107:1050-1058.
62. [62] Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822-H827.
63. [63] Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-456.
64. [64] McCall T, Whittle BJR, Boughton-Smith NK, Moncada S. Inhibition of fMLP induced aggregation of rabbit neutrophils by nitric oxide. Br J Pharmacol 1988;85:517P.
65. [65] Carey C, Siegfried MR, Ma X-L, Weyrich AS, Lefer AM. Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion. Circ Shock 1992;38:209-216.
66. [66] Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action in the NADPH oxidase. J Clin Invest 1992;90:1116-1121.
67. [67] Moilanen E, Vuorinen P, Kankaanranta H, MetsaKetela T, Vapatalo H. Inhibition by nitric oxide-donors of human polymorphonuclear leukocyte function. Br J Pharmacol 1993;109:852-858.
68. [68] Forslund T, Sundqvist T. Nitric oxide reduces hydrogen peroxide production from human polymorphonuclear neutrophils. Eur J Clin Invest 1995;25:9-14.
69. [69] Lefer DJ, Klunk DA, Lutty GA, Merges C, Schleimer RP, Bochner BS, Zweier JL. Nitric oxide (NO) donors reduce basal ICAM-1 expression on human aortic endothelial cells (HAEC's). Circulation 1993;88[part 2]:I-565 (abstract).
70. [70] Gauthier TW, Davenpeck KL, Lefer AM. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol 1994;267:G562-G568.